XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.21.1

Stock-Based Compensation | 3 Months Ended
--- | ---
Mar. 31, 2021
Stock-Based Compensation [Abstract] |
Stock-Based Compensation | 4. Stock-Based Compensation No awards were granted during the three-month period ended March 31, 2021. As of March 31, 2021, there was $160,000 of total unrecognized compensation cost related to non-vested options granted in 2020 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2021. Compensation costs related to stock options amounted to $54,000 and $51,000 during the three-month periods ended March 31, 2021 and 2020, respectively. A summary of the Company’s stock option activity for the three-month period ended March 31, 2021 is as follows:
|  |  | Weighted |  |  |  |  |
|  |  | Average Exercise |  | Weighted Average |  | Aggregate
|  |  | Price |  | Remaining |  | Intrinsic Value
| Options |  | Per Share |  | Contractual Term |  | ($000)
Outstanding at January 1, 2021 | 215,970 |  | $ | 25.73 |  | 6.0 | Yrs. |  | $ | 743
Granted | — |  |  | — |  | — |  |  |  | —
Exercised | (3,750) |  |  | 19.03 |  | 2.6 |  |  |  | 28
Forfeited | (2,250) |  |  | 33.72 |  | 7.7 |  |  |  | —
Outstanding at March 31, 2021 | 209,970 |  | $ | 25.76 |  | 5.8 | Yrs. |  | $ | 758
Exercisable at March 31, 2021 | 176,220 |  | $ | 25.54 |  | 5.1 | Yrs. |  | $ | 758
Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $26.61 per share as of March 31, 2021 and $26.17 per share as of December 31, 2020. A summary of the Company’s restricted stock activity for the three-month periods ended March 31, 2021 and 2020 is as follows:
| 2021 |  | 2020
|  |  | Weighted-Average |  |  |  |  | Weighted-Average
| Number of |  | Grant Date |  | Number of |  | Grant Date
| Restricted Stock |  | Fair Value |  | Restricted Stock |  | Fair Value
Non-vested, January 1, | 39,135 |  | $ | 30.72 |  | 36,195 |  | $ | 36.23
Granted | — |  |  | — |  | — |  |  | —
Vested | — |  |  | — |  | — |  |  | —
Forfeited | (3,900) |  |  | 30.86 |  | — |  |  | —
Non-vested, March 31, | 35,235 |  | $ | 30.71 |  | 36,195 |  | $ | 36.23
The expected future compensation expense relating to the 35,235 shares of non-vested restricted stock outstanding as of March 31, 2021 is $998,000. This cost will be recognized over the remaining vesting period of 4.75 years. Compensation costs related to restricted stock amounted to $84,000 during the three-month periods ended March 31, 2021 and 2020.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration